Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,142
-$433,937 QoQ
Shares Held
11,122
-64.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Graham Capital Management, L.P. holds $14,869,409 across 66 Biotechnology names. MGNX ranks #66 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
4,606 | $870,764 | |
| 2 | TECH |
BIO-TECHNE Corp
|
9,949 | $519,934 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
22,442 | $488,337 | |
| 4 | BHVN |
Biohaven Ltd.
|
55,399 | $468,675 | |
| 5 | NUVL |
Nuvalent, Inc.
|
4,112 | $421,274 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
45,222 | $407,450 | |
| 7 | MNKD |
Mannkind Corp
|
161,189 | $394,913 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
112,831 | $393,780 |
All Filings in MGNX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,142 | 11,122 | Shares | Sole | 2026-05-15 | |
| 2024-03-31 | $466,079 | 31,663 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $85,427 | 18,332 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $114,634 | 21,427 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $217,746 | 32,451 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $710,511 | 205,350 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,074,664 | 364,293 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $575,425 | 65,315 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $172,842 | 10,769 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||